Published: Sat, November 18, 2017
Business | By Max Garcia

Today's Brokerage Rating: Henry Schein, Inc. (HSIC), Equifax Inc. (EFX)

Finally, Jefferies Group LLC reaffirmed a hold rating and issued a $88.50 price target on shares of Henry Schein in a research note on Friday, July 21st. Leerink Swann set a $183.00 price target on Henry Schein and gave the company a "hold" rating in a research report on Wednesday, February 22nd. UBS AG restated a "buy" rating on shares of Henry Schein in a research report on Friday, September 15th. Henry Schein, Inc. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.55 and a quick ratio of 0.86.

Henry Schein, Inc. most recently reported earnings per share (EPS) of $0.87 for the September 2017 versus $0.84 in the same quarter past year, representing 4% growth.

Wipro Limited (NYSE:WIT) [Trend Analysis] also deem for profitability analysis, in recent session share price swings at $5.12 with change of -0.97%. The stock has a consensus rating of Hold and a consensus target price of $89.88. (NASDAQ:HSIC)'s stock was -8.36%. The stock has a market capitalization of $10,668.19, a price-to-earnings ratio of 19.07, a price-to-earnings-growth ratio of 1.91 and a beta of 1.03. Henry Schein has a one year low of $146.23 and a one year high of $183.00. For this HSIC's 20 days and 50 days MA (moving average) comparison clear the blur picture. Henry Schein's quarterly revenue was up 10.3% compared to the same quarter last year. research analysts predict that Henry Schein, Inc. will post 3.6 EPS for the current fiscal year. In the latest earnings report the EPS was $3.47 with 156.95M shares now outstanding. The firm had revenue of $3.16 billion during the quarter, compared to analysts' expectations of $3.05 billion.

TheStreet lowered shares of Henry Schein, Inc.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Monday, November 6th. During the same quarter past year, the company earned $1.67 EPS. Champlain Investment Partners, LLC now holds 908,795 shares with a value of $74,512,000.

In other Henry Schein news, Director Kurt P. Kuehn bought 1,000 shares of the business's stock in a transaction dated Monday, December 12th. The shares were sold at an average price of $172.51, for a total transaction of $366,756.26. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. The stock was sold at an average price of $173.62, for a total value of $752,469.08. The disclosure for this sale can be found here. The company's market cap is $11.08 Billion, and the average volume is 1.8 Million.

Whereas, firm has insider ownership was declared as 0.10% and Insider transaction was recorded recently as -1.29%.

Several large investors have recently modified their holdings of the company. The value of the investment in (HSIC) increased from $2,304,000 to $2,820,000 a change of $516,000 quarter over quarter. (NASDAQ:HSIC) established that the company was able to keep return on investment at 14.11 in the trailing twelve month while Reuters data showed that industry's average stands at 13.31 and sector's optimum level is 14.42. Fisher Asset Management LLC boosted its position in shares of Henry Schein by 99.3% during the third quarter. Sun Life Financial INC now owns 580 shares of the company's stock valued at $106,000 after purchasing an additional 573 shares during the last quarter. Swedbank boosted its position in shares of Henry Schein by 84.9% during the third quarter. A statistical measure of the dispersion of returns (volatility) for HSIC producing salvation in Investors mouth, it has week volatility of 2.78% and for the month booked as 2.69%. Atlanta Capital Management Co.

WARNING: "Henry Schein, Inc". Balyasny Asset Management LLC now holds 460,792 shares worth $37,780,000.

COPYRIGHT VIOLATION NOTICE: "Henry Schein, Inc". The Company's segments include healthcare distribution, and technology and value-added services.

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners.

Like this: